Carregant...
Targeting of the Diabetes Prevention Program leads to substantial benefits when capacity is constrained
OBJECTIVE: Approximately 84 million people in the US have pre-diabetes, but only a fraction of them receive proven effective therapies to prevent type 2 diabetes. We estimated the value of prioritizing individuals at highest risk of progression to diabetes for treatment, compared to non-targeted tre...
Guardat en:
| Publicat a: | Acta Diabetol |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8276501/ https://ncbi.nlm.nih.gov/pubmed/33517494 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00592-021-01672-3 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|